Literature DB >> 8129778

Cytokine combinations increase p75 tumor necrosis factor receptor binding and stimulate receptor shedding in rheumatoid synovial fibroblasts.

D J Taylor1.   

Abstract

OBJECTIVE: To identify cytokines responsible for the increased levels of tumor necrosis factor receptor (TNFR) in the joints of patients with rheumatoid arthritis.
METHODS: Antibodies to TNFR types were used both to inhibit ligand cell binding and to quantify released receptors in rheumatoid synovial fibroblasts.
RESULTS: Binding by and shedding of the p75 TNFR was affected by interleukin-1 (IL-1), IL-4, and interferon-gamma.
CONCLUSION: IL-1 could cause increased TNF alpha binding and TNFR shedding in inflamed joints.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129778     DOI: 10.1002/art.1780370212

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

Review 1.  Etanercept: a review of its use in rheumatoid arthritis.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

2.  Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts.

Authors:  D J Taylor
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

3.  Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis.

Authors:  J Neidel; M Schulze; J Lindschau
Journal:  Inflamm Res       Date:  1995-05       Impact factor: 4.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.